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Abstract G,, and G,i, differ from other G protein a subunits in that they have unique, conserved 6 residue amino-terminal extensions. Wild-type 
and amino-terminal mutants of G,. expressed in COS cells were analyzed for their ability to functionally couple with co-expressed neurokinin NK2 
receptor. Wild-type, T2A and 42-7 G,+ were able to stimulate agonist driven phospholipase C (PLC) activity in identical manners. Other activities 
of these two amino-terminal mutants including aluminum fluoride stimulated PLC activity, palmitoylation, interaction with G,, subunits and 
GTPyS-induced trypsin resistance are also similar to the wild-type c1 subunit. This demonstrates that the NK2 receptor is able to functionally interact 
with the a subunit of G, and that the first seven amino-acids of Gqs are not required for any of the a subunit functions tested. In contrast to the 
T2A and 42-7 mutants, a C9,lOA G,,, mutant was not able to couple to either the NK2 receptor or PLC, as assessed by high-affinity agonist binding 
and activation of PLC either in intact cells or in vitro. The C9,lOA protein was able to assume a GTP@-induced trypsin-resistant conformation and 
partitioned prhnarily to the pelletable fraction in a manner similar to the wild-type protein. However, it was not labeled with [Hlpahnitic acid. This 
suggests that blocking palmitoylation at the amino-terminus of G,= results in a loss of functional activity which reflects an inability to interact with 
both the receptor and downstream signaling targets. 
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1. Introduction 
Amino-termini of the a subunits of heterotrimeric G proteins 
have been shown to be essential for both interaction with GB, 
dimers and association with particulate cellular fractions [l-3]. 
The amino-term% of many, if not all, G protein a subunits also 
undergo lipid modification [4]. Pahnitoylation of cysteine resi- 
dues located close to the amino-termini of many G protein 
a subunits is thought to be important for interaction with recep- 
tors, effecters and membrane association [5--g]. It is a dynamic 
modification which can be regulated by G protein activation 
[9,10]. The amino-termini of both Gqol and Gii, differ from 
those of other G a subunits in that they contain a unique 
conserved six-amino acid extension. In this report we describe 
the effects of removing or modifying this extension and block- 
ing pahnitoylation on Gqa function. 
2. Materials and methods 
2.1. Plasm& and transfection 
The genes for G,,, G, and G, kindly provided by M. Simon, were 
amplified by PCR using primers which placed a consensus eukaryotic 
translation initiation sequence [ 111 at the 5’ end of the gene and cloned 
into pSG5 (Stratagene). The histidine-tagged GB subunit, pSG5/Gp 
3’His, differs from the wild-type sequence by the addition of Asp(I-Iis), 
to its carboxy-terminus. The NK2 receptor expression vector pCDU 
NK2/Flag was derived from pCDL/NK2 [ 121 as described in [ 131. Each 
of the mutants and all PCR amplified products were confirmed by 
DNA sequencing. COS-7 cells were transfected by electroporation. 
2.2. Intact cell phospholipase assay 
COS-7 cells were assayed for phospholipase activity using a protocol 
modified from P. Godfrey [14]. Cells at 72 h post-transfection were 
harvested with PBS, 1 mM EDTA, washed twice with PBS, and resus- 
pended in inositol-free DMEM (Gibco BRL) containing 20 ,UJiiml 
[5-3H]cytidine (NEN) at a density of 1 x 10’ cells per ml. Aliquots of 
0.3 ml were placed at 37°C. After 1 h, 15~1 of 210 mM LiCl was added. 
After an additional 15 min at 37”C, 15 ~1 of the NK2 selective agonist 
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GR64349 [151 in 10 mM acetic acid or vehicle was added. The cultures 
were held at 37°C for 30 min. Radiolabeled CDP-diacylglycerol (CMP- 
phosphatidic acid) was measured by extracting the cells in 940 ~1 meth- 
anol/chloroformAICl (200:100: 1) on ice for 20 min. Chloroform, 
300 ~1, and water, 300 ~1, were added to each sample. The samples were 
then vortexed and centrifuged at 2,000 x g for 15 min. From the lower 
organic phase, 0.4 ml was taken and added to 1 ml of 0.5 M HCl, 50% 
methanol. The samples were vortexed and spun at 2,000 x g for 15 min. 
Again from the lower phase, 0.2 ml was taken and placed in a scintilla- 
tion vial. The chloroform was allowed to evaporate and the samples 
counted. Each point was assayed in triplicate and each assay was 
independently repeated at least 3 times. 
2.3. Cell fractionation, immunoblotting and immunoprecipitation 
Approximately 2 x 10’ transfected cells were resuspended in 1 ml of 
buffer G (50 mM HEPES, 100 mM NaCl, 3 mM MgCl,, 1 mM EDTA, 
pH 7.5) supplemented with 2 mM PMSF, 1 &ml antipain, 5 ,&ml 
aprotinin and 1 &ml leupeptin. Cells were lysed by homogenization 
in a glass homogenizer. Lysates were centrifuged at 1,000 x g for 5 min, 
then at 100,000 x g for 30 min. The 100,000 x g pellet was washed twice 
more in G buffer. Antisera 92A and 93A were raised against peptides 
equivalent o mouse G, amino acids 350-359 and 119-134, respec- 
tively. For metabolic labelling of Gqb, 5 x 10’ transfected cells were 
placed in 0.3 ml DMEM F12 containing either 100 @i/ml [9,10- 
‘H]palmitic acid (NEN) or 100 @ml L-[3sS]methionine (Amersham). 
After 4 h at 37”C, the cells were pelleted, resuspended in 1 .O ml RIPA 
buffer and immunoprecipitated using antisera 92A. 
2.4. NK 2 receptor binding and activation of recombinant PLCpl 
For binding, 125-250 pg of membrane protein was diluted in buffer 
N (25 mM Tris, 100 mM NaCl, 3 mM MnQ, 0.2% BSA, pH 7.4) and 
incubated for 2 h at room temperature with 0.5-1.0 nM of the NK2 
receptor antagonist radioligand’ [‘H]SR48968 (Amersham) [16] and 
NKA. GTPyS was included at 100 PM where indicated. Binding was 
terminated by rapid filtration through glass fibre filters (GF/B) pre- 
soaked with 0.5% (v/v) polyethylenimine followed by 3 washes of 4.0 
ml with ice-cold buffer N. Bovine PLC&?l produced in Schizosaccharo- 
myces pombe (S. Arkinstall and K. Maundrell, unpublished) was as- 
sayed as described [17. 
2.5. Interaction with G,, subunits 
Particulate fractions from approximately 2 x 10’ cells were resus- 
pended in 0.5 ml G buffer. G buffer, 0.5 ml, containing 2% luberol PX, 
was added and the fractions were incubated on ice for 1 h. After 
centrifugation at 100,000 x g for 20 min, solubilized polyhistidine- 
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tagged Ga2 subunits were bound by the addition of 0.2 ml 50% Ni-NTA 
slurry (Qiagen) in G buffer plus 1% luberol PX to the resulting super- 
natant. The mixtures were incubated at room temperature for 30 min 
with gentle agitation and then loaded into a small column. The resin 
was washed with 3.0 ml G buffer, 1% luberol PX, followed by 1.0 ml 
of the same buffer plus 10 mM imidazole. Bound proteins were eluted 
with 1.0 ml G buffer, 1% luberol PX, 250 mM imidazole. 
3. Results 
3.1. Characterization of wild-type and mutant Gqa proteins 
The predicted amino acid sequences of both G,, and Gllcr 
differ from those of most other G protein a subunits in that they 
contain a unique six-amino acid extension preceding the 
methionine codon used in the initiation of most other G pro- 
teins. Mutant Gqa genes encoding T2A, 42-1, C9,lOA or 42-21 
proteins were created to test the role of this extension, and also 
potential pahnitoylation sites located at positions 9 and 10, in 
Gqa function. The first two mutants, T2A and 42-1, were used 
to test the role of the unique N-terminal extension. The T2A 
mutant was designed in analogy with a similar G2A mutant of 
G,, which was shown to decrease the affinity of the G, subunit 
for GB, and adenylylcyclase [18]. The third mutant, C9,10A, 
was designed to prevent addition of pahnitic acid to the amino- 
terminal cysteine residues of Gqar. The final mutant, 42-27, was 
designed to mimic a tryptically cleaved G, subunit and to serve 
as a control for loss of amino-terminal function. Fig. 1 shows 
an immunoblot of soluble and particulate fractions from COS 
cells that were transiently expressing each of these CI subunits. 
Each of the proteins can be seen to fractionate to both the 
particulate and soluble fractions. 
Proteins from cells expressing the C9,lOA mutant or other 
forms of G, were labelled in vivo with either [3H]pahnitic acid 
or [35S]methionine and then immunoprecipitated with anti-G, 
antiserum 92A (data not shown). Wild-type, T2A and 42-l G, 
were all labelled with pahnitic acid. However, 42-7 G,, was 
seen to he labelled with palmitic acid to a somewhat lesser 
extent than wild-type and T2A G, proteins. As expected [8], 
the C9,lOA and 42-27 mutants failed to become labelled with 
palmitic acid. 
3.2. Interaction of G,, and Gqa mutants with the NK2 receptor 
Fig. 2A shows that when the NK2 receptor is transiently 
expressed in COS cells it is able to stimulate production of 
SG5 WT T2A A2-7 A2-27C9,lOA 
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Fig. 1. Fractionation properties of G,, subunits expressed in COS-7 
cells. Equal numbers of COS-7 cells transfected with vectors encoding 
wild-type or mutant G, were lysed and separated into soluble (S) ?vd 
particulate (P) fractions by centrifugation at 100,000 x g for 20 mm. 
Equal proportions of the extracts were assayed for G,, content by 
immunoblotting with anti-Gg, antiserum 93A. Similar esults were ob- 
tained in six independent experiments. 
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Fig. 2. Agonist-stimulated phospholipase activity by G,, and G, mu- 
tants. Transfected COS-7 cells were assayed for their ability to produce 
CDP-diacyglycerol (CMP-phosphotidic a id) [14] in response to addi- 
tion of increasing amounts of the NK2 selective agonist GR64349. 
(A) NK2 receptor (o), G,, T2A (o), NK2 receptor plus G,, T2A (m), 
vector without insert (0). (B) Wild-type G,& 0, Gqa T2A (o), G,, 42-7 
(w), G,, C9,lOA (o), G,, 42-27 (A), vector without insert (0). Error bars 
represent s andard errors of the mean from triplicate assays from a 
single experiment. Comparable results were obtained in three similar 
experiments. 
[3H]CDP-DAG, a measure of phospholipase C activation [14], 
when treated with the NK2-selective agonist GR64349 [15]. 
Cells transfected with plasmids encoding both the NK2 recep- 
tor and Gg, show a marked increase in agonist-dependant phos- 
pholipase activity. Excess GR100679, an NK2 selective antago- 
nist [19], was able to block agonist-induced G,,-dependent 
phospholipase activity (data not shown). From this we con- 
clude that Gqar is able to interact with the NK2 receptor to 
stimulate phospholipase activity in COS-7 cells. 
As shown in Fig. 2B, addition of agonist to cells expressing 
the NK? receptor and either the T2A or the 42-7 mutants 
stimulates CDP-diacylglycerol accumulation to the same extent 
as was observed for cells expressing the wild-type G, subunit. 
However, the C9,lOA and 42-27 mutants both fail to enhance 
agonist-stimulated phospholipase activity, indicating that the 
C9,lOA and 42-27 proteins are unable to interact with receptor 
and/or effector in this assay. These results show that the first 
26 residues of G,, are required for normal protein function, as 
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Fig. 3. AlF-induced stimulation of phospholipase activity by G,, mu- 
tants. COS-7 cells transfected with vectors expressing G, a subunits 
were assayed for their ability to produce CDP-diacyglycerol [14] in 
response to the addition of 2.5 ,uM AlCl, together with 2.5 mM NaF 
or NaCl. Error bars represent s andard errors of the mean from trip- 
licate assays from a single experiment. Comparable results were ob- 
tained in three similar experiments. 
are cysteines and presumably pahnitate modification at resi- 
dues 9 and/or 10. In contrast, neither threonine-2 nor the first 
6 amino acids of the protein are required for full activity. 
3.3. Aluminum $uoride activation of mutant G, a subunits 
To localize the lesion in the transduction chain created by the 
C9,lOA and 42-27 mutations, we have assayed receptor-inde- 
pendent phospholipase activity by direct activation using alu- 
minum fluoride. As shown in Fig. 3, wild-type Gpa stimulated 
phospholipase activity in a manner similar to the T2A and 42-7 
mutants, while the C9,lOA and 42-27 mutants completely 
failed to stimulate [3H]CDP-diacylglycerol accumulation over 
background. This pattern is nearly identical to that observed 
for receptor stimulated phospholipase activation. This suggests 
that the lesion in receptor-linked [‘H]CDP-DAG generation 
(Fig. 2) is due, at least in part, to a decrease in the ability of 
the C9,lOA and 42-27 mutant G proteins to functionally inter- 
act with endogenous phospholipase(s). 
3.4. Detergent solubilization and interaction with GBy 
Because the first 18-28 amino acids of several different G, 
subunits have been shown to be necessary for tight association 
with G,, subunits and a G2A G, mutant has been shown to 
reduce GB,-dependant G, activity [18], we sought to test each 
G,+ mutant for their ability to interact with By subunits. We 
began by solubilizing the G a subunits from particulate frac- 
tions using detergents. Luberol PX (1%) was found to solubilize 
endogenous Gga and most of the over-expressed wild-type, T2A 
and 42-7 a subunits. However, the amount of protein solubil- 
ized from particulate fractions of cells expressing C9,lOA or 
42-27 proteins was never greater than that extracted from cells 
transfected with vector alone. Similar results were obtained 
with 1% sodium cholate, Triton X-100, Triton X-l 14, or n- 
octylglucoside (data not shown). Interaction of G, with j?y 
subunits was assayed by co-transfecting COS-7 cells with ex- 
pression vectors encoding: wild-type, T2A or 42-7 G, subunits, 
G,,, and a G, protein which was modified to include an addi- 
tional six carboxy-terminal histidine residues. Solubilized G 
protein a, /I and y subunits were loaded onto a Ni-NTA col- 
umn, washed extensively, and then eluted with buffer contain- 
ing 250 mM imidazole. Fig. 4 shows an immunoblot of un- 
bound and eluted material from cells expressing Gg, alone, 
GB,-His and G,, or GB,-His, Gr2 plus each of the three active 
G4 a subunits. Wild-type, T2A and 42-7 G4= can all be seen to 
elute from the column in a manner dependent on the presence 
of the poly-histidine-tagged G,,. This assay demonstrates that 
each of the three G, subunits is capable of interacting with G,, 
dimers containing G,. Thus, the T2A and 42-7 mutations do 
not block association of G, with G,, dimers. 
3.5. Pelletable C9,lOA protein is not active 
The inability of the C9,lOA and 42-27 proteins to activate 
phospholipase in intact cells (Figs. 2 and 3), together with the 
observation that they could not be solubilized by mild detergent 
extraction, suggests that they are not associated with the partic- 
ulate fraction in the same manner as wild-type G,. We further 
assayed the pelletable C9,lOA protein for function using two 
in vitro assays: (i) formation of a GTPyS-sensitive high-affinity 
agonist-binding state in the NIU receptor, and (ii) in vitro 
activation of recombinant PLCBl. Fig. 5A shows that a clear 
increase in high affinity neurokinin A binding is detectable at 
low agonist concentrations in particulate fractions prepared 
from cells co-expressing the NK2 receptor and T2A G,,. No 
such change was observed with the C9,lOA mutant or control 
cells transfected with the vector alone. Importantly, increased 
high affinity agonist binding with T2A G,, was abolished in the 
presence of GTPyS. Fig. 5B shows that while T2A G, (used 
here instead of wild-type) in COS cell particulate fractions 
activated PLCjIl following preincubation with GTPyS, partic- 
ulate fractions containing the C9,lOA mutant were totally inac- 
tive under identical conditions. Together, these data show that 
the pelletable C9,lOA protein is unable to functionally interact 
with receptor or effector. 
+ Ij2(3’His)+y2 
Gaq 'SG5 WT T2A A2-7 
'U B"U BI'U B"U B "U B 
Fig. 4. Interaction of G, a subunits with G&Y&Q. Luberol extracts 
from particulate fractions of COS-7 cells expressing G, and/or G,, 
plus a G, modified to contain a carboxy-t&minai extksion of six 
histidine residues, were mixed with Ni-NTA agarose and loaded into 
a small column. Flow-through was collected, the column was washed 
with 10 ~01s. of buffer followed by an additional 5 ~01s. of buffer with 
10 mM imidazole. and then eluted with buffer contain&z 250 mM 
imidazole. Equal amounts of flow-through (U) and eluted (6) material 
were analysed for G,, content by immunoblotting anti-Gqi,, antiserum 
93A. Data shown is representative of three independent experiments. 
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Fig. 5. Interaction of NK2 receptor with Gpa in the particulate fraction. 
Particulate fractions from transfected COS-7 cells were assayed for (A) 
GTPyS-induced changes in agonist affiity or (B) GTPyS-stimulated 
activation of PLCjIl. (A) NKA competition with [%IlSR48968 for 
binding to NK2 receptor in the presence (filled symbols) and absence 
(open symbols) of 100 PM GTPyS. G,= T2A (squares), Gq. C9,lOA 
(circles), vector (triangles). (B) In vitro activation of recombinant 
PLQ31. Particulate fractions preincubated with (IiIIed bars) or without 
(open bars) 100 PM GTPyS were assayed for their ability to activate 
PLC/31 in crude S. pombe xtracts. Data points are means from tripli- 
cate measurements a  each point. Data shown are from a single exper- 
iment which is representative of two (antagonist displacement) or three 
(PLC activation) independent experiments. 
4. Discussion 
Agonist binding to tachykinin receptors has been shown to 
stimulate phospholipase activity in several different systems 
[12,20,21]. It has been suggested that this activity is transduced 
through G,, as addition of purified G,,,, to a partially purified 
NKl (substance P) receptor preparation augments high affinity 
agonist binding [22]. In this report we have shown that G, is 
capable of coupling to the NK2 receptor when the two proteins 
are co-expressed in COS cells. 
The G, and Glla genes are predicted to encode proteins with 
amino-terminal extensions of 6 amino acids relative to the 
amino-termini of most other G protein a subunits. This exten- 
sion is predicted to occur in mouse and Xenopus Gqol subunits, 
and also in mouse, human, cow and turkey G,,, subunits. We 
have assayed T2A and 42-7 G,, for their ability to transduce 
signals from the NK2 receptor, to directly stimulate PLC, to 
interact with GB, dimers, and to become pahnitoylated. These 
amino acids are not required for any of these functions. The 
only difference we have detected is a decrease in the pahnitoyl- 
ation of the 42-7 mutant. This could reflect a reduced affinity 
for the putative pahnitoyl transferase, an increase in nucleotide 
exchange rate [9,10], or a reduction in the amount of properly 
folded material. 
Wedegaertner et al. [8], working in HEK cells, have pub- 
lished an elegant series of experiments which demonstrate that 
lipidation of Gg, is required for signal transduction via the 
aZadrenoceptor and activation of PLC. Their results differ 
from ours primarily in that non-palmitoylated G,_,= was not 
pelletable in their system. Such a result is consistent with the 
demonstrated role of pahnitoylation in membrane association 
of H-ras and GAP-43 [23,24]. Despite this, we and others 
[6,7,25] have not found significant differences in the fractiona- 
tion properties of either pahnitoylation-defective or amino-ter- 
minally truncated mutant a subunits compared to the 
wild-type protein when expressed in COS cells. The pelletable, 
non-palmitoylated Gsa is unable to interact with either the NK2 
receptor or PLCbl (Fig. 5), nor could it be solubilized by 
detergent extraction (data not shown). This suggests that the 
pelletable protein may be present in an inactive, possibly aggre- 
gated, form. However, immunoblots of soluble Gs6 from cells 
expressing C9,lOA and 42-27 proteins show that both are able 
to attain GTPyS-dependant trypsin-resistant conformations 
(data not shown), indicating that some of the soluble protein 
is properly folded. Thus, we can not rule out the possibility that 
the protein is associated with some other cellular component, 
such as the cytoskeleton, in such a manner as to render it unable 
to stimulate phospholipase activity or interact with the 
receptor. 
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